Velocity Clinical Research Valparaiso is a clinical research site located in Valparaiso, Indiana, United States 46383.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Velocity Clinical Research Valparaiso has participated in 24 clinical trials with 10 currently active.
Therapeutic areas: Atherosclerotic Cardiovascular Disease, Overweight, Obesity.
Sponsors: Amgen, Eli Lilly and Company, Bond Avillion 2 Development LP.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in Valparaiso
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Velocity Clinical Research Valparaiso has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Velocity Clinical Research Valparaiso has 24 clinical trials on record, with 10 currently active. Their work covers Atherosclerotic Cardiovascular Disease, Overweight, Obesity.
Velocity Clinical Research Valparaiso has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.